# Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.

> **NCT02868827** · PHASE2,PHASE3 · TERMINATED · sponsor: **King Abdullah Medical City** · enrollment: 127 (actual)

## Conditions studied

- Vitamin D Deficiency
- Critical Illness

## Interventions

- **DRUG:** Cholecalciferol
- **OTHER:** Milk (Nestle)

## Key facts

- **NCT ID:** NCT02868827
- **Lead sponsor:** King Abdullah Medical City
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-27
- **Primary completion:** 2019-11-09
- **Final completion:** 2019-11-09
- **Target enrollment:** 127 (ACTUAL)
- **Why stopped:** The initial plan was 2 years but due to slow recruitment. We were able to screen 635 patients in 4 years and recruited only 127 patients.
- **Last updated:** 2020-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868827, "Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02868827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*